Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2013-03-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ambu AuraOnce Versus Ambu AuraGain LM in Children
NCT02811042
A Comparison of the Ambu AuraGain Versus LMA Supreme in Children
NCT02380768
Laryngeal Mask Airway Supreme Versus Laryngeal Tube
NCT02252120
A Comparison of the Laryngeal Mask Airway (LMA) - Unique and LMA-Supreme in Children
NCT01653795
A Randomized Comparison of LMA (Laryngeal Mask Airway) Supreme and LMA Proseal in Infants Below 10kg
NCT02478983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laryngeal mask Ambu AuraOnce
laryngeal mask Ambu AuraOnce
laryngeal mask Ambu AuraOnce
airway management and mechanical ventilation with laryngeal mask
laryngeal mask LMA Supreme
laryngeal mask LMA Supreme
laryngeal mask LMA Supreme
airway management and mechanical ventilation with laryngeal mask
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laryngeal mask Ambu AuraOnce
airway management and mechanical ventilation with laryngeal mask
laryngeal mask LMA Supreme
airway management and mechanical ventilation with laryngeal mask
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I - III
* Elective procedure in general anaesthesia
* Parental informed consent
Exclusion Criteria
* Body mass index \> 35 kg/m2
* Cervical spine pathologies or peripheral neurologic deficiences
* Malformations of upper airway or head
* Anamnestic hiatus hernia or esophageal reflux
* Status post operation of stomach or esophagus
* Recurrent respiratory infection or obstructive airway disease
* Non elective procedure
1 Year
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University Innsbruck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Paal
Peter Paal, MD, DESA, EDIC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Paal, MD,DESA,EDIC
Role: PRINCIPAL_INVESTIGATOR
University Hospital Innsbruck, Department of Anaesthesia + Intensive Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Innsbruck
Innsbruck, Tyrol, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AN4111 292/4.23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.